Skip to content
Clinical ResearchResearch compound

Super‑Shred (lipotropic blend)

A custom-mixed fat-burner cocktail given by injection, with carnitine and albuterol; it can be dangerous for the heart and is banned in sport.

Super-Shred (lipotropic blend) vial

DETAILED OVERVIEW

What is Super-Shred (lipotropic blend)?

Super-Shred (lipotropic blend) is a custom-mixed fat-burner cocktail given by injection. It combines five ingredients: L-carnitine, a trio that helps the liver handle fat (methionine, inositol and choline), ATP, albuterol (a drug that opens the airways) and vitamin B12. No approved product of this kind exists; it is made at home or through individual pharmacy compounding.

The idea is that carnitine helps burn fat and albuterol speeds up fat breakdown by producing heat. The evidence for fat loss is mostly for the individual ingredients, and there is no controlled study of the blend. The main risk comes from albuterol: it can cause a fast heartbeat, hand tremor, low potassium and strain on the heart. Because of albuterol it is banned in competitive sport. In home-made or grey-market mixes, purity and sterile production are not guaranteed, the real albuterol content may differ from the label, and an abscess can develop at the injection site. It cannot be used with heart rhythm disorders or high blood pressure, or during pregnancy and breastfeeding.

Type

Compounded injectable lipotropic fat-burner cocktail (5-component 'lipo shot')

Composition

L-carnitine, methionine, inositol, choline, ATP, albuterol and vitamin B12

Mechanism

Fatty-acid shuttle (carnitine) + hepatic lipotropics (MIC) + beta-2 thermogenic (albuterol) + cofactors (ATP, B12)

Administration

Subcutaneous / intramuscular injection (aqueous solution)

Legal status

No approved fixed-dose blend exists; compounded / grey-market. Albuterol beta-2 agonist is WADA-banned (oral/injectable). EU + HU: Rx components.

Composition

This stack contains the following peptides

MIC Blend (Methionine, Inositol, Choline)

Role: Lipotropic trio (Methionine + Inositol + Choline) – supports hepatic lipid metabolism and fat export; choline + methionine are methyl donors
100 mg

ATP

Role: Cellular energy / substrate component
50 mg

B12 (cyanocobalamin)

Role: Cyanocobalamin – cofactor in energy and methyl metabolism, added for energy support
1 mg

Data console

Lab data

Androgenic:AnabolicN/A (not AAS)
AR bindingN/A
Active half-lifeComponent-dependent: albuterol ~5-6 h, L-carnitine ~15 h, B12 is stored
Detection windowAlbuterol 24-72 h urine (WADA threshold 1000 ng/mL). L-Carnitine is not a standard WADA test; B12 / lipotropics are not listed.
AromatizationDoes not aromatize – not a steroid. The blend consists of lipotropics, a beta-2 agonist and cofactors, with no CYP19 (aromatase) interaction and no estrogen-axis effect.
HepatotoxicityThe lipotropic components (choline, methionine, inositol) generally SUPPORT hepatic fat metabolism and fat export, so they are not hepatotoxic on their own. Honest note: because Super-Shred is a compounded / grey-market injectable, purity, sterile manufacturing and actual active content are NOT guaranteed – here the risk comes not from hepatotoxicity but from the purity and sterility uncertainty of home formulation and from the cardiovascular effect of the albuterol.

Safety

Side effects, stop signs, contraindications

Side effects · 8

  • Tachycardia and palpitations: the Albuterol beta-2 agonist effect raises heart rate and causes palpitations, especially at higher doses or combined with other stimulants.
  • Hand tremor (fine shaking): beta-2 receptor stimulation causes a characteristic, dose-dependent skeletal-muscle tremor, most often in the hands.
  • Hypokalaemia (low blood potassium): beta-2 activation shifts potassium into cells, which can cause muscle weakness and arrhythmia risk, especially alongside diuretics.
  • Restlessness, anxiety, insomnia: the sympathomimetic effect of Albuterol can cause nervousness, inner tension and disturbed sleep.
  • Headache and muscle cramps: a common beta-2 agonist side effect; the cramping can be aggravated in part by hypokalaemia.
  • Injection-site reaction and sterility risk: with grey-market/compounded aqueous injectables purity and sterility are not guaranteed, so local pain, inflammation, abscess or infection can occur.
  • Dose uncertainty (compounded mix): the actual Albuterol content can deviate significantly from the labelled amount, causing unpredictable cardiovascular load.
  • L-Carnitine TMAO elevation: chronic carnitine intake can be converted by gut microbiota to TMAO, which has been linked over the long term to atherosclerosis risk (Koeth 2013).

Contraindications · 7

  • Pre-existing tachyarrhythmia, atrial fibrillation or cardiomyopathy: the Albuterol beta-2 effect worsens the arrhythmia, an absolute contraindication.
  • Untreated or severe hypertension (>140/90 mmHg): the sympathomimetic load further raises blood pressure.
  • Hyperthyroidism / Graves disease: contraindicated due to heightened adrenergic sensitivity and arrhythmia risk.
  • Pregnancy and breastfeeding: the beta-2 agonist crosses over and has tocolytic/cardiovascular effects; the compounded mix has no established safety.
  • Concurrent beta-blocker or MAO-inhibitor therapy: a beta-blocker blocks the effect and may cause vasoconstriction, while with an MAO inhibitor there is a risk of hypertensive crisis and tachycardia.
  • Combination with another beta-2 agonist/stimulant (clenbuterol, ECA stack, caffeine): additive cardiac stress and hypokalaemia, contraindicated.
  • WADA-tested athletes: injectable/oral Albuterol beta-2 agonist use is prohibited in competition (only inhaled <1600 ug/24h is permitted).

Related Performance Compounds

Same therapeutic category

Studies

Related research and clinical findings

Telegram

Have a question about Super‑Shred (lipotropic blend)?

Reach out to an advisor on Telegram. Performance compounds are presented with a harm-reduction approach, based on peer-reviewed evidence.

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant

MolekulaX Editorial Team·Source-verified · PubMed · FDA · EMA
Updated: October 14, 2026

The information here is for educational and scientific purposes only. Performance-enhancing compounds (AAS, prohormones, stimulants, doping agents) are illegal without prescription in Hungary and most of the EU, and carry serious health and legal risks. WADA bans them in competitive sport. This is NOT a usage guide, and we do not encourage any illegal use. If you do use them, medical supervision and regular bloodwork are ESSENTIAL. Severe endocrine, cardiovascular, hepatic and psychiatric side effects are possible.